Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse Transcriptase

Samankaltaisia teoksia

• Engineering of a Chimeric RB69 DNA Polymerase Sensitive to Drugs Targeting the Cytomegalovirus Enzyme
  Tekijä: Tchesnokov, Egor P., et al.
  Julkaistu: (2009)
• Mechanisms Associated with HIV-1 Resistance to Acyclovir by the V75I Mutation in Reverse Transcriptase
  Tekijä: Tchesnokov, Egor P., et al.
  Julkaistu: (2009)
• Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against “Nucleotide-competing Reverse Transcriptase Inhibitors”
  Tekijä: Ehteshami, Maryam, et al.
  Julkaistu: (2008)
• Connection Domain Mutations N348I and A360V in HIV-1 Reverse Transcriptase Enhance Resistance to 3′-Azido-3′-deoxythymidine through Both RNase H-dependent and -independent Mechanisms
  Tekijä: Ehteshami, Maryam, et al.
  Julkaistu: (2008)
• Pre-steady-state Kinetic Studies Establish Entecavir 5′-Triphosphate as a Substrate for HIV-1 Reverse Transcriptase
  Tekijä: Domaoal, Robert A., et al.
  Julkaistu: (2007)